Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
ACETO CORP (ACETQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/01/2019 8-K Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or ...
Docs: "Amended and Restated Certificate of Incorporation",
"Amended and Restated Bylaws",
"Second Amendment to the Tax Asset Protection Rights Agreement, between Aceto Corporation and American Stock Transfer & Trust Company, LLC, as Rights Agent"
09/20/2019 8-K Bankruptcy or Receivership, Material Modifications to Rights of Security Holders, Departure of Directors or Certain Officers;...
Docs: "The Second Modified Joint Plan of Liquidation of Aceto Corporation and Its Affiliated Debtors",
"Confirmation Order"
08/26/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "July 2019 Monthly Operating Report of Aceto Corporation"
08/15/2019 8-K Quarterly results
08/02/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "May 2019 Monthly Operating Report of Aceto Corporation"
07/16/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "April 2019 Monthly Operating Report of Aceto Corporation"
07/02/2019 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Financial Statements and Ex...
Docs: "Amendment to the Tax Asset Protection Rights Agreement, between Aceto Corporation and American Stock Transfer & Trust Company, LLC, as Rights Agent"
06/18/2019 8-K Quarterly results
06/03/2019 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
Docs: "Amendment to Change in Control Agreement between Aceto Corporation and William C. Kennally"
05/17/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "April 2019 Monthly Operating Report of Aceto Corporation"
05/03/2019 8-K Termination of a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointmen...
04/30/2019 8-K Completion of Acquisition or Disposition of Assets
04/25/2019 8-K Completion of Acquisition or Disposition of Assets
04/17/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Post-Petition Key Executive Incentive Agreement, by and between Aceto Corporation and William C. Kennally, III"
04/15/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc. PORT WASHINGTON, N.Y., April 12, 2019 -- ACETO Corporation, an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received approval from the U.S. Bankruptcy Court to sell the assets of Rising Pharmaceuticals and Rising’ s subsidiaries to Shore Suven Pharma, Inc. for gross cash proceeds of $15 million, plus the assumption of operating liabilities and customer obligations related to the acquired business, on a cash-free and debt-free basis. The sale was conducted through a Court-supervised process under Section 363 of the Bankruptcy Code..."
04/03/2019 8-K Quarterly results
04/01/2019 8-K Entry into a Material Definitive Agreement
03/08/2019 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Asset Purchase Agreement, by and among Rising Pharmaceuticals, Inc., PACK Pharmaceuticals, LLC, Rising Health, LLC, Acetris Health, LLC, as sellers, Aceto Corporation, as parent, and Shore Suven Pharma, Inc., as buyer",
"Equity Commitment Letter, by and between (i) Suven Life Sciences, Ltd., Vimal Kavuru, Shore Pharma Investments, LLC, and Casper Pharma Private Limited, and (ii) Shore Suven Pharma, Inc",
"Mutual Release of Claims, by and between (i) Aceto Corporation, Rising Pharmaceuticals, Inc., Acetris Health, LLC, and Rising Health, LLC, and (ii) Shore Pharma LLC, Cedar Pharma LLC (f/k/a Citron Pharma LLC), Aster Pharma LLC (f/k/a Lucid Pharma LLC), Citgen Pharma Holding LLC, Gensource Pharma LLC, SS Pharma LLC, Pharma Reach LLC, Citgen Realty LLC, Sudha Kavuru, Vimal Kavuru and Subha Sri Thogarchedu"
02/22/2019 8-K Quarterly results
01/08/2019 8-K Entry into a Material Definitive Agreement
11/09/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "(unaudited) Assets"
11/06/2018 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "Certificate of Amendment of Restated Certificate of Incorporation establishing the Series A Participating Cumulative Preferred Stock of Aceto Corporation",
"Tax Asset Protection Rights Agreement, between Aceto Corporation and American Stock Transfer & Trust Company, LLC, as Rights Agent, which includes the Form of Certificate of Amendment of Restated Certificate of Incorporation establishing the Series A Participating Cumulative Preferred Stock of Aceto Corporation as Exhibit A, the Form of Right Certificate as Exhibit B and the Summary of Rights as Exhibit C",
"ACETO Corporation Adopts Rights Plan Designed to Preserve Valuable Net Operating Loss Carryforwards and Other Tax Benefits"
09/28/2018 8-K Quarterly results
09/27/2018 8-K Quarterly results
09/12/2018 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Third Amendment and Limited Waiver to Second Amended and Restated Credit Agreement, among Aceto Corporation, certain loan parties thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent"
07/16/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release"
06/05/2018 8-K Quarterly results
05/04/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Aceto Corporation and Subsidiaries Consolidated Statements of Operations"
04/23/2018 8-K Other Events
04/18/2018 8-K Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment...
Docs: "Press Release"
02/27/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Press Release issued by Aceto Corporation"
02/16/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Letter Agreement between the Company and Edward J. Borkowski",
"Change in Control Agreement between the Company and Edward Borkowski",
"Press Release issued by Aceto Corporation"
02/02/2018 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Aceto Corporation and Subsidiaries Consolidated Statements of Income Three Months Ended Six Months Ended December 31, December 31, 2017 2016 2017 2016 Net sales $ 171,229 $ 125,552 $ 356,484 $ 253,570 Cost of sales 137,259 94,747 282,531 191,926 Gross profit 33,970 30,805 73,953 61,644 Gross profit % 19.8 % 24.5 % 20.7 % 24.31 % Selling, general and administrative expenses 28,063 28,071 59,212 49,095 Research and development expenses 2,122 1,341 3,737 2,391 Operating income 3,785 1,393 11,004 10,158 Other expense, net of interest expense income before income taxes 1,639 5,846 Income tax provision 13,365 15,049 2,025 Net income $ $ $ $ 3,821 Net income per common share $ $ $ $ 0.13 Diluted net income per common share $ $ $ $ 0.13 Weighted average shares outstanding: Basic 35,210 30,029 ..."
12/18/2017 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "First Amendment to Second Amended and Restated Credit Agreement, by and among the Company, certain other loan parties party thereto, the lenders party thereto, and Wells Fargo Bank, National Association, as administrative agent"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy